The Association between Buprenorphine Treatment Duration and Mortality: A Multi‐site Cohort Study of People who Discontinued Treatment

Jason M. Glanz,Ingrid A. Binswanger,Christina L. Clarke,Anh P. Nguyen,Morgan A. Ford,G. Thomas Ray,Stanley Xu,Rulin C. Hechter,Bobbi Jo H. Yarborough,Douglas W. Roblin,Brian Ahmedani,Joseph A. Boscarino,Susan E. Andrade,Carmen L. Rosa,Cynthia I. Campbell

Addiction（2022）

引用 6|浏览25

暂无评分

摘要

Among patients who discontinue buprenorphine treatment, there appears to be no treatment duration period associated with a reduced risk for all-cause mortality. Patients who discontinue buprenorphine treatment after 91-180 days appear to be at heightened risk for opioid overdose compared with patients who discontinue after > 365 days of treatment.

查看译文

关键词

Buprenorphine,cohort,mortality,opioid,opioid use disorder,overdose

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要